AKT1 and colorectal carcinoma: Collectively, the data suggest that kynurenine pathway metabolites disrupt the stability of GSK-3β and activate PI3K/AKT signaling in CRC cells, which together contribute to the nuclear translocation of β-catenin and subsequently drive cell proliferation [140, 144].